GERN INVESTOR DEADLINE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GERN INVESTOR DEADLINE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit#GERN…

Geron Corp: How Concerned Should We Be About Rytelo Sales?

Geron Corp: How Concerned Should We Be About Rytelo Sales? #Geron #Corp #Concerned #Rytelo #Sales

Geron Corp's chief commercial officer buys $160,000 in stock

Geron Corp's chief commercial officer buys $160,000 in stock#Geron #Corp039s #chief #commercial #officer #buys #stock

Geron: Lackluster Stock Performance Despite Reasonable Drug Launch (NASDAQ:GERN)

This article was written by Follow Scientist and trader of biotech stock. Focus on trading around…

Geron: Positive IMpactMF Trial Could Possibly Lead To Doubling Of RYTELO Sales

Geron: Positive IMpactMF Trial Could Possibly Lead To Doubling Of RYTELO Sales #Geron #Positive #IMpactMF #Trial…